Unknown

Dataset Information

0

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.

ABSTRACT:

SUBMITTER: Shaw RH 

PROVIDER: S-EPMC8115940 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine.
| S-EPMC8767802 | biostudies-literature
Unknown Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England.
| S-EPMC8284043 | biostudies-literature
Unknown Heterologous prime-boost strategies for COVID-19 vaccines.
| S-EPMC8754745 | biostudies-literature
Unknown Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
| S-EPMC8321428 | biostudies-literature
Unknown To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination.
| S-EPMC8425437 | biostudies-literature
Unknown Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
| S-EPMC6486346 | biostudies-literature
Unknown Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study.
| S-EPMC8520818 | biostudies-literature
Unknown Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers.
| S-EPMC8402499 | biostudies-literature
Unknown Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates.
| S-EPMC8009122 | biostudies-literature
Unknown Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
| S-EPMC8360702 | biostudies-literature